After a two day virtual meeting the African Union (AU) has announced the launch of a partnership programme to manufacture vaccines at five new research centres. They will be built on the continent within the next 15 years as assured. Both, the Coalition for Epidemic Preparedness Innovations (CEPI), which helps run the global COVAX coronavirus vaccine-sharing programme with the public-private alliance Gavi and the World Health Organization (WHO) have signed a memorandum of understanding to boost African vaccine research and development as well as establishing manufacturing.
According to John Nkengasong, director of the Africa Centres for Disease Control and Prevention (CDC), the five centres will be located in the north, south, east, west and centre of Africa over the next 10-15 years.
He said on Tuesday after the meeting that “Trusted partnership will be critical in advancing the vaccine manufacturing agenda on the continent,” “The partnership with CEPI symbolises cooperation and collaboration to help respond to infectious disease threats and ensure Africa’s health security.”
Scope of the collaboration
As part of the expanded relationship, CEPI, the African Union, the Africa CDC will work to:
John Nkengasong wrote on Twitter, “Great session on partnership with @SongweVera @franciscollin12 @ggao___ to advance vaccines manufacturing in Africa. Thanks so much for @AfricaCDC”.
Inputs from Africa Centres for Digital Control and Prevention (CDC)
Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…
Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…
Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…
Kais Saied, the Tunisian president has said in his speech that he will allow the…
You know the credibility of an ingredient when it’s plastered all over bottles and jars…
Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…
This website uses cookies.